Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.1393
-0.0407 (-22.61%)
At close: Apr 8, 2025

Rapid Dose Therapeutics Revenue

In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M CAD with 104.34% growth. Rapid Dose Therapeutics had revenue of 668.58K in the quarter ending February 28, 2025, with 247.04% growth.

Revenue
2.09M CAD
Revenue Growth
+104.34%
P/S Ratio
12.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
18.71M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021755.20K653.70K644.06%
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition